Alessandra Bertolucci, MD
Synthetic dopamine agonists including study drugs have shown benefit in Parkinson's Disease (PD) as an adjuvant therapy. Drugs affect neurotransmitters in the retina where dopamine has been shown to be reduced and dependant neurons appear swollen and distorted. This study is designed as a longitudinal study to rule out effects on the retina.
Study results are currently being analyzed. Please visit this webpage next month for the study update.
For more information: